Literature DB >> 25664074

Role of rCBV values derived from dynamic susceptibility contrast-enhanced magnetic resonance imaging in differentiating CNS lymphoma from high grade glioma: a meta-analysis.

Ruofei Liang1, Mao Li1, Xiang Wang1, Jiewen Luo1, Yuan Yang1, Qing Mao1, Yanhui Liu1.   

Abstract

BACKGROUND AND
PURPOSE: In the preoperative period, discriminating CNS lymphoma from high grade glioma is important as treatment approaches differ significantly. Hence, this meta-analysis was to evaluate the sensitivity and specificity of the relative cerebral blood volume (rCBV) values derived from dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSCE-MRI) in differentiating CNS lymphoma from high grade glioma.
MATERIALS AND METHODS: The following databases were searched from January 2000 to July 2014: Medline, PubMed and Embase. No language restrictions were applied. Data analysis was conducted using Meta-Disc 1.4.
RESULTS: A total of 79 patients (n = 30 lymphoma, n = 49 high grade glioma) and 89 lesions (n = 40 lymphoma, n = 49 high grade glioma) were included in the rCBV analysis. The pooled sensitivity, specificity, negative likelihood ratio, positive likelihood ratio and diagnostic odds ratio for differentiating CNS lymphoma from high grade glioma were 0.90 (95% CI 0.76-0.97), 0.98 (95% CI 0.89-1.00), 0.13 (95% CI 0.06-0.29), 21.07 (95% CI 5.61-79.19), and 187.63 (95% CI 33.15-1061.86), respectively. And the value of I(2) of DOR was 0.0%, indicating that there was no statistically significant heterogeneity of DOR between the included studies.
CONCLUSIONS: Our meta-analysis suggests that the rCBV values derived from DSCE-MRI could be useful in differentiating CNS lymphoma from high grade glioma in the preoperative. Further well-designed researches involving larger patient cohorts are needed to confirm this conclusion.

Entities:  

Keywords:  CNS lymphoma; high grade glioma; meta-analysis; rCBV values

Year:  2014        PMID: 25664074      PMCID: PMC4307521     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

Review 1.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

Authors:  Soonmee Cha; Edmond A Knopp; Glyn Johnson; Stephan G Wetzel; Andrew W Litt; David Zagzag
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

2.  Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature.

Authors:  M Reni; A J Ferreri; M P Garancini; E Villa
Journal:  Ann Oncol       Date:  1997-03       Impact factor: 32.976

3.  Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma.

Authors:  U Herrlinger; M Schabet; M Clemens; R D Kortmann; D Petersen; B E Will; R Meyermann; J Dichgans
Journal:  Acta Neurol Scand       Date:  1998-04       Impact factor: 3.209

4.  Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions.

Authors:  J H Ma; H S Kim; N-J Rim; S-H Kim; K-G Cho
Journal:  AJNR Am J Neuroradiol       Date:  2010-06-25       Impact factor: 3.825

5.  Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.

Authors:  Yusuhn Kang; Seung Hong Choi; Young-Jae Kim; Kwang Gi Kim; Chul-Ho Sohn; Ji-Hoon Kim; Tae Jin Yun; Kee-Hyun Chang
Journal:  Radiology       Date:  2011-10-03       Impact factor: 11.105

6.  Investigating brain tumor differentiation with diffusion and perfusion metrics at 3T MRI using pattern recognition techniques.

Authors:  Patricia Svolos; Evangelia Tsolaki; Eftychia Kapsalaki; Kyriaki Theodorou; Kostas Fountas; Ioannis Fezoulidis; Ioannis Tsougos
Journal:  Magn Reson Imaging       Date:  2013-07-30       Impact factor: 2.546

7.  Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.

Authors:  C H Toh; K-C Wei; C-N Chang; S-H Ng; H-F Wong
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

8.  Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors.

Authors:  Stanley Lu; Daniel Ahn; Glyn Johnson; Soonmee Cha
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

9.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.

Authors:  F A Howe; S J Barton; S A Cudlip; M Stubbs; D E Saunders; M Murphy; P Wilkins; K S Opstad; V L Doyle; M A McLean; B A Bell; J R Griffiths
Journal:  Magn Reson Med       Date:  2003-02       Impact factor: 4.668

10.  Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

Authors:  Penny F Whiting; Marie E Weswood; Anne W S Rutjes; Johannes B Reitsma; Patrick N M Bossuyt; Jos Kleijnen
Journal:  BMC Med Res Methodol       Date:  2006-03-06       Impact factor: 4.615

View more
  5 in total

1.  Presurgical Identification of Primary Central Nervous System Lymphoma with Normalized Time-Intensity Curve: A Pilot Study of a New Method to Analyze DSC-PWI.

Authors:  A Pons-Escoda; A Garcia-Ruiz; P Naval-Baudin; M Cos; N Vidal; G Plans; J Bruna; R Perez-Lopez; C Majos
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

2.  Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.

Authors:  Koung Mi Kang; Seung Hong Choi; Park Chul-Kee; Tae Min Kim; Sung-Hye Park; Joo Ho Lee; Soon-Tae Lee; Inpyeong Hwang; Roh-Eul Yoo; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn
Journal:  Eur Radiol       Date:  2021-05-18       Impact factor: 5.315

3.  An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals.

Authors:  Mamatha B Nijaguna; Vikas Patil; Alangar S Hegde; Bangalore A Chandramouli; Arimappamagan Arivazhagan; Vani Santosh; Kumaravel Somasundaram
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

Review 4.  The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.

Authors:  Weilin Xu; Qun Wang; Anwen Shao; Bainan Xu; Jianmin Zhang
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

5.  Astrocytoma progression scoring system based on the WHO 2016 criteria.

Authors:  Zhen-Hang Li; Yan-Lei Guan; Qiang Liu; Yao Wang; Run Cui; Yun-Jie Wang
Journal:  Sci Rep       Date:  2019-01-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.